
View larger version (69K):
[in this window]
[in a new window]
|
Fig. 1. E2-2B induces a full EMT when overexpressed in MDCK cells. (A) Phenotypic characterisation of MDCK-E2-2B cells. Phase-contrast images of MDCK-CMV control cells (a) and one representative clone from MDCK-E2-2B cells, C2 (b). Scale bar: 100 µm. Immunofluorescence images of EMT markers, in MDCK-CMV (c,e,g,i) and MDCK-E2-2B, C2 cells (d,f,h,j). E-cad, E-cadherin; FN, fibronectin; N-cad, N-cadherin; VM, vimentin. F-actin stain in MDCK-CMV (k) and MDCK-E2-2B (l) cells. White arrows indicate lamellipodia-like structures. Scale bar: 50 µm. (B) Western blot analysis of E2-2B-HA and the indicated epithelial and mesenchymal markers in MDCK-CMV and three independent clones from MDCK-E2-2B cells. -Tubulin levels are shown as a loading control. (C) Immunofluorescence images showing the nuclear localization of E2-2B-HA protein. Panels a,b: control MDCK-CMV; c,d: MDCK-E2-2B, C2 cells. Scale bar: 40 µm. (D,E) Semiquantitative RT-PCR analysis to detect the expression of the exogenous E2-2B (D, upper panel) and endogenous Cdh1 (D, middle panel) transcripts and of endogenous dog E47, Snail1and Snail2 in the indicated clones and control cells (E). GAPDH levels are shown as a loading control.
|